26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

chemotactic peptide 165 Chido (Ch) and Rodgers (Rg) antigens<br />

These chemotactic factors are derived from both inflammatory<br />

and noninflammatory cells including neutrophils, macrophages,<br />

smooth muscle cells, fibroblasts, epithelial cells,<br />

and endothelial cells. MCP-1 participates in the recruitment<br />

of monocytes in various pathologic or physiologic conditions.<br />

Neutrophil chemotaxis assays are performed using the<br />

microchamber technique. Chemotactic assays are also useful<br />

to reveal the presence of chemotaxis inhibitors in serum.<br />

chemotactic peptide<br />

A peptide that attracts cell migration, such as formylmethionyl-leucyl-phenylalanine.<br />

chemotactic receptor<br />

Cellular receptor for chemotactic factor. In bacteria, such<br />

receptors are designated sensors and signalers and are<br />

associated with various transport mechanisms. The cellular<br />

receptors for chemotactic factors have not been isolated<br />

and characterized. In leukocytes, the chemotactic receptor<br />

appears to activate a serine proesterase enzyme, which sets in<br />

motion the sequence of events related to cell locomotion. The<br />

receptors appear specific for the chemotactic factors under<br />

consideration, and apparently the same receptors mediate all<br />

types of cellular responses inducible by a given chemotactic<br />

factor. However, these responses can be dissociated from<br />

each other, suggesting that binding to the putative receptor<br />

initiates a series of parallel, interdependent, and coordinated<br />

biochemical events leading to one or another type of<br />

response. Using a synthetic peptide, N-formyl-methionylleucyl-phenylalanine,<br />

about 2000 binding sites have been<br />

demonstrated for each polymorphonuclear neutrophil (PMN)<br />

leukocyte. The binding sites are specific, have a high affinity<br />

for the ligand, and are saturable. Competition for the binding<br />

sites is shown only by the parent or related compounds; the<br />

potency of the latter varies. Positional isomers may inhibit<br />

binding. Full occupancy of the receptors is not required for a<br />

maximal response, and occupancy of only 10 to 20% of them<br />

is sufficient. The presence of spare receptors may enhance<br />

the sensitivity in the presence of small concentrations of<br />

chemotactic factors and may contribute to the detection<br />

of a gradient. There also remains the possibility that some<br />

substances with chemotactic activity do not require specific<br />

binding sites on cell membranes.<br />

Chemotactic factor<br />

f. Met - Leu - Phe<br />

Chemotaxis.<br />

PMN<br />

Leukocytes<br />

Micropore filter<br />

chemotaxis<br />

The process whereby chemical substances direct cell movement<br />

and orientation. The orientation and movement of<br />

cells in the direction of a concentration gradient constitute<br />

positive chemotaxis, whereas movement away from the<br />

concentration gradient is termed negative chemotaxis.<br />

Substances that induce chemotaxis are referred to as<br />

chemotaxins and are often small molecules, such as C5a,<br />

formyl peptides, lymphokines, bacterial products, leukotriene<br />

B 4, etc., that induce positive chemotaxis of polymorphonuclear<br />

neutrophils, eosinophils, and monocytes.<br />

These cells move into inflammatory agents by chemotaxis.<br />

Chemotaxis is measured by using a dual-chamber device<br />

called a Boyden chamber, in which phagocytic cells in culture<br />

are separated from a chemotactic substance by a membrane.<br />

The number of cells on the filter separating the cell<br />

chamber from the chemotaxis chamber reflect the chemotactic<br />

influence of the chemical substance for the cells.<br />

chemotherapy<br />

Treatment of neoplasia with chemical drugs that destroy<br />

tumor cells that grow more rapidly than do normal cells or<br />

have a metabolic disorder.<br />

chickenpox (varicella)<br />

Human herpesvirus type 3 (HHV-3) induced in acute<br />

infection that usually occurs in children below 10 years of<br />

age. There is anorexia, malaise, low fever, and a prodromal<br />

rash following a 2-week incubation period. Erythematous<br />

papules appear in crops and intensify for 3 to 4 days. They<br />

are very pruritic. Complications include viral pneumonia,<br />

secondary bacterial infection, thrombocytopenia, glomerulonephritis,<br />

myocarditis, and other conditions. HHV-3<br />

may become latent when chickenpox resolves. Its DNA may<br />

become integrated into the dorsal route ganglion cells that<br />

may be associated with the development of herpes zoster or<br />

shingles later in life.<br />

Phenotype<br />

C4d Component<br />

Present<br />

Frequency (%)<br />

Whites<br />

Ch(a+), Rg(a+) C4dS, C4df 95<br />

Ch(a–), Rg(a+) C4df 2<br />

Ch(a+), Rg(a–) C4dS 3<br />

Ch(a–), Rg(a–) None Very rare<br />

Chido (Ch) and Rodgers (Rg) Antigens<br />

Chido (Ch) and Rodgers (Rg) antigens<br />

Epitopes of C4d fragments of human complement component<br />

C4. They are not intrinsic to the erythrocyte<br />

membrane. The Chido epitope is found on C4d from C4B,<br />

whereas the Rodgers epitope is found on C4A derived from<br />

C4d. The Rodgers epitope is Val–Asp–Leu–Leu, and the<br />

Chido epitope is Ala–Asp–Leu–Arg. They are situated<br />

at residue positions 1188 and 1191 in the C4d region of<br />

the C4 α chain. Antibodies against Ch and Rg antigenic<br />

determinants agglutinate saline suspensions of red blood<br />

cells coated with C4d. Because C4 is found in human<br />

serum, anti-Ch and anti-Rg are neutralized by sera of most<br />

individuals having the relevant antigens. Ficin and papain<br />

destroy these antigens.<br />

C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!